Entity

Biogen

Biogen is a biotechnology company that develops and sells therapies for neurological diseases, including Alzheimer's disease.

Why it’s in the news: It is in the news due to new data on its Alzheimer's drug and the development of its tau therapy.

Latest on Biogen

STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and more
STAT+: Biogen Alzheimer’s drug slowed decline at rates on par with approved therapies, study shows
STAT+: All eyes on data on Biogen’s tau therapy

2 entities linked to Biogen across the news graph.

Also connected to (2)